AngioDynamics to Report Fiscal 2021 Fourth Quarter and Full-Year Financial Results and Host Investor & Technology Day on July 13, 2021
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the fourth quarter and fiscal year 2021 before the market open on Tuesday, July 13, 2021. The Company’s management will host a conference […]
Read More →Lamb Weston Announces Details of Fiscal Fourth Quarter and Fiscal 2021 Earnings Release and Conference Call
EAGLE, Idaho–(BUSINESS WIRE)–Lamb Weston Holdings, Inc. (NYSE: LW) will report its fiscal fourth quarter and fiscal 2021 financial results on Tuesday, July 27, 2021. The news release will be issued at approximately 8:30 a.m. EDT. Lamb Weston will host a conference call on Tuesday, July 27, 2021 at 10 a.m. EDT to discuss the results. […]
Read More →OSE Immunotherapeutics Reports on its 2021 Virtual Combined General Shareholder’s Meeting
NANTES, France–(BUSINESS WIRE)–Regulatory News: OSE Immunotherapeutics (Paris:OSE) (ISIN: FR0012127173; Mnemo: OSE) today announced that all the resolutions submitted to a vote at the Combined General Shareholders’ Meeting were approved as proposed by OSE Immunotherapeutics’ Board of Directors. The Company conducted the General Meeting virtually following the provisions of the French ordinances related to COVID-19, dated […]
Read More →Graphite Bio Announces Pricing of Upsized Initial Public Offering
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Graphite Bio, Inc., a clinical-stage, next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases, today announced the pricing of its upsized initial public offering of 14,000,000 shares of its common stock at a price to the public of $17.00 per share. All […]
Read More →Hilltop Holdings Inc. Announces Change in Location of the 2021 Annual Meeting of Stockholders to a Virtual-Only Format
DALLAS–(BUSINESS WIRE)–Hilltop Holdings Inc. (NYSE: HTH) (“Hilltop”) determined that, due to continued public health and safety concerns related to the coronavirus (COVID-19) pandemic, the location of Hilltop’s 2021 Annual Meeting of Stockholders (the “Annual Meeting”) has been changed to a virtual-only format. Stockholders will not be able to attend the Annual Meeting in person. As […]
Read More →L.A. Community Hearing on Homelessness, Housing and Hunger
LOS ANGELES–(BUSINESS WIRE)–Housing Is A Human Right (HHR) and key state and local legislators will host a “Community Hearing on Homelessness, Housing and Hunger” on Friday, June 25th in Downtown Los Angeles. The hearings will include 3 panel discussions with public testimony (‘Hunger’ at 11:00 a.m., ‘Housing’ at 1:30 p.m. and ‘Homelessness’ at 3:00 p.m.) […]
Read More →CodeCombat Featured at the 33rd Annual International Olympiad in Informatics
SAN FRANCISCO–(BUSINESS WIRE)–As the world’s most prestigious global coding competition for secondary school students, the International Olympiad in Informatics (IOI) utilized CodeCombat’s game-based competitive coding platform to challenge the programming skills of some of the world’s strongest coders, in a unique head-to-head coding competition. “As a part of the programming team that developed the CodeCombat […]
Read More →Apogee Enterprises Declares Quarterly Cash Dividend
MINNEAPOLIS–(BUSINESS WIRE)–Apogee Enterprises, Inc. (Nasdaq: APOG) announced today that its Board of Directors has declared a quarterly cash dividend of $0.20 per share. The dividend will be payable on July 29, 2021 to shareholders of record at the close of business on July 14, 2021. About Apogee Enterprises, Inc. Apogee Enterprises, Inc. (Nasdaq: APOG) delivers […]
Read More →ADDING and REPLACING Otolith Labs Announces Closing of $3.3 Million in Seed Financing; Receives “Breakthrough Device” Designation from FDA for Its Prescription Treatment for Vertigo
WASHINGTON–(BUSINESS WIRE)–Add after last paragraph of release: Caution: Investigational device limited by United States law to investigational use. Note: Revenue is from Department of Defense Research Grants and is non-sales related. The updated release reads: OTOLITH LABS ANNOUNCES CLOSING OF $3.3 MILLION IN SEED FINANCING; RECEIVES “BREAKTHROUGH DEVICE” DESIGNATION FROM FDA FOR ITS PRESCRIPTION TREATMENT […]
Read More →Empower, Ltd. Announces Effectiveness of Registration Statement and Extraordinary Meeting Date for Proposed Business Combination with Holley
BOWLING GREEN, Ky.–(BUSINESS WIRE)–Empower, Ltd. (NYSE: “EMPW” “EMPW-UN” and “EMPW-WT”) (“Empower”), a publicly-traded special purpose acquisition company, today announced that the U.S. Securities and Exchange Commission (“SEC”) has declared effective its Registration Statement on Form S-4 (as amended, the “Registration Statement”), which includes a definitive proxy statement/prospectus in connection with Empower’s extraordinary general meeting of […]
Read More →